Cell Systems News — Coronavirus
The COVID-19 pandemic has upended much of the global economy. While most individual's lives have been disrupted, we are still seeing tremendous progress in the scientific community to research this virus and ultimately create a vaccine. As a provider of primary cells to researchers around the world, Cell Systems is ready to ship cells, media and reagents to enable valuable research to continue. Though the insights surrounding this virus are still in the early stage, there has been some interesting papers surrounding COVID-19 and vascular biology -- particularly endothelial cells, including this one in The Lancet. Cell Systems has a large...